Anúncio
Anúncio
GBIO
Generation Bio Co. Common Stock
5.70
USDPatrocinado
+0.11
+1.97%
31 de dez., 15:59 UTC -5
Encerrado
Pós-Mercado
5.70
0.00
0.00%
Relatórios de Lucros GBIO
Rácio de surpresa positiva
GBIO separação 11 de 22 últimas estimativas.
50%
Próximo Relatório
Data do Próximo Relatório
11 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$442.00K
/-$5.00
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-72.27%
/+509.76%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-89.45%
/+56.25%
Generation Bio Co. Common Stock earnings per share and revenue
On 05 de nov. de 2025, GBIO reported earnings of -0.82 USD per share (EPS) for Q3 25, beating the estimate of -3.23 USD, resulting in a 74.68% surprise. Revenue reached 1.59 milhão, compared to an expected 673.20 mil, with a 136.78% difference. The market reacted with a -3.28% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analistas forecast an EPS of -5.00 USD, with revenue projected to reach 442.00 mil USD, implying an aumentar of 509.76% EPS, and diminuir of -72.27% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Generation Bio Co. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Generation Bio Co. Common Stock reported EPS of -$0.82, beating estimates by 74.68%, and revenue of $1.59M, 136.78% above expectations.
How did the market react to Generation Bio Co. Common Stock's Q3 2025 earnings?
The stock price moved down -3.28%, changed from $5.19 before the earnings release to $5.02 the day after.
When is Generation Bio Co. Common Stock expected to report next?
The next earning report is scheduled for 11 de mar. de 2026.
What are the forecasts for Generation Bio Co. Common Stock's next earnings report?
Based on 7
analistas, Generation Bio Co. Common Stock is expected to report EPS of -$5.00 and revenue of $442.00K for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio